Pharm
Venlafaxine
search
Venlafaxine
, Effexor, Venlafaxine Withdrawal
See Also
Desvenlafaxine
(
Pristiq
)
Serotonin Norepinephrine Reuptake Inhibitor
(
SNRI
)
SNRI Overdose
Indications
Major Depression
including refractory cases
Considered to be second-line agent
Generalized Anxiety Disorder
Obsessive Compulsive Disorder
Post-Traumatic Stress Disorder
Mechanism
Similar activity as
Tricyclic Antidepressant
s
Serotonin Norepinephrine Reuptake Inhibitor
Selective Serotonin Reuptake Inhibitor
(<150 mg/day)
Both
Serotonin
and
Norepinephrine
Reuptake Inhibitor (>150 mg/day)
Minimally inhibits
Dopamine
uptake
Pharmacokinetics
Venlafaxine Regular Release
Half life: 5 to 11 hours
Safety
Unknown safety in
Lactation
Pregnancy Category C
Preparations
Venlafaxine
Venlafaxine regular release (Effexor)
Available as 25, 37.5, 75, 100 mg tablets (scored)
Start: 25 mg PO tid
Effective dose: 150-225 mg per day divided bid to tid
Maximum dose: 375 mg per day
Disadvantages: More adverse effects than Effexor XR
Advantages: May be dosed once daily since metabolites offer similar duration to Effexor XR
Venlafaxine extended release (Effexor XR)
Available as 37.5, 75, 150 mg (capsules)
Start: 37.5 to 75 mg orally daily
Maximum: 225 mg orally daily
Indications to decrease dose by 50% (or 25% if mild organ
Impairment
)
Hepatic
Impairment
Renal
Impairment
or
Hemodialysis
Adverse Effects
Prominent Withdrawal symptoms
See also
Antidepressant Withdrawal
Symptoms start 1-3 days after stopping medication (mild symptoms may have onset within hours of missed pill)
Dizziness
Irritability
Insomnia
Headache
Gastrointestinal upset
Ataxia
or
Vertigo
Paresthesia
s (including shock-like
Sensation
s)
Tachycardia
Fever
Effexor taper schedule
Reduce dose 25 mg/day every 5-7 days
Taper to 25-50 mg/day before stopping
Effexor XR taper schedule
Reduce dose 37.5 to 75 mg per day every 7 days
Taper to 37.5 mg/day before stopping
Alternatives to tapering with Effexor
Start
Sertraline
(
Zoloft
) 50 mg orally daily on stopping Effexor
Adverse Effects (more common with regular release Effexor)
Anticholinergic
(less than
Tricyclic Antidepressant
s)
Dizziness
Somnolence
Dry Mouth
Nausea
or
Vomiting
May be severe and limit dosing
Start therapy at 25 mg per day
Increased
Blood Pressure
Only seen with total daily doses 300 mg or higher
Less
Sexual Dysfunction
than
Prozac
,
Zoloft
,
Paxil
Sexual Dysfunction
in 10-15% of cases
Similar to
Luvox
and
Celexa
See
Antidepressant Induced Sexual Dysfunction
More stimulating (anxiogenic) than sedating
Agitation
or
Insomnia
may occur
Decreased appetite and Weight loss may occur
Photosensitivity
Suicidal Ideation
and self harm (children)
Ocular changes
Increased Intraocular Pressure
(
Exercise
caution in
Glaucoma
)
Mydriasis
Drug Interactions
Minimal
Cytochrome P450
interactions
Metabolized by
CYP2D6
and
CYP3A4
Avoid with
MAO Inhibitor
s (including
Linezolid
)
Exercise
caution when combining with
Cimetidine
or
Haloperidol
Risk of
Serotonin Syndrome
(as with other
SNRI
and with
SSRI
)
Monitor closely with
Triptan
s
Resources
Venlafaxine (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=55889b3d-74c9-4638-9a14-6a4ca3a99f7f
References
(2023) Med Lett Drugs Ther 62(1592): 25-32
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 38-9
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Mishler and Lovecchio (2017) Crit Dec Emerg Med 31(11): 15-20
(1997) Am J Psych 154:1760 [PubMed]
Sundberg (1995) Depression Primary Care, PGM, p. 45-57
Type your search phrase here